In contrast, among patients without ETE or with tumors ≤2 cm, the difference in CSD between N1a and N1b disease did not reach statistical significance.
← all excerpts
ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden.
1
—
—